Whether the induction of OX40 expression on T cells in the TME induced by CpG in A20 but not in B78 tumors reflects the differences in the cancer cell biology of the A20 and B78 tumor or the differences in the CpG responsiveness of immune cells invading these two tumors requires further study. The gene discussed is TNFRSF4; the disease is cancer.